Taiwan Liposome Company, Ltd. American Depository Shares
TLC
TLC was delisted on the 28th of September, 2021.
7 hedge funds and large institutions have $3.58M invested in Taiwan Liposome Company, Ltd. American Depository Shares in 2019 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 7 → 7 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
34% less capital invested
Capital invested by funds: $5.46M → $3.58M (-$1.88M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$6.96K |
| 2 |
AG
Advisor Group
Phoenix,
Arizona
|
+$1.68K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$1.44M |
| 2 |
Millennium Management
New York
|
-$19K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
KPC
1
Karst Peak Capital
Hong Kong
| $3.02M | – | – | – |
|
|
2
Millennium Management
New York
| $497K | -$19K | -3,400 | -3% |
|
3
Creative Planning
Overland Park,
Kansas
| $53K | – | – | – |
|
|
4
UBS Group
Zurich,
Switzerland
| $7K | +$6.96K | +1,245 | +3,365% |
|
|
HR
5
Howe & Rusling
Rochester,
New York
| $3K | – | – | – |
|
|
AG
6
Advisor Group
Phoenix,
Arizona
| $3K | +$1.68K | +300 | +150% |
|
|
7
Morgan Stanley
New York
| $1K | -$1.44M | -257,350 | -100% |
|
TLC Hedge Fund Activity: Q2 2019 in Review
7 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Taiwan Liposome Company, Ltd. American Depository Shares (TLC) for Q2 2019, worth a combined $3.58M — down 34% from $5.46M a quarter earlier.
Fund positioning in TLC was balanced in Q2 2019: 0 funds opened new positions, 0 closed out, 2 added to existing stakes and 2 trimmed.
The largest buyer was UBS Group, adding an estimated $6.96K. The largest seller was Morgan Stanley, cutting an estimated $1.44M.
- 7 institutional investors held Taiwan Liposome Company, Ltd. American Depository Shares (TLC) as of Q2 2019, unchanged from Q1 2019.
- Funds reported $3.58M of Taiwan Liposome Company, Ltd. American Depository Shares stock for Q2 2019, down 34% quarter-over-quarter.
- 0 funds opened new Taiwan Liposome Company, Ltd. American Depository Shares positions in Q2 2019 and 0 closed out.
- The largest Taiwan Liposome Company, Ltd. American Depository Shares buyer in Q2 2019 was UBS Group, an estimated $6.96K added.
- The largest Taiwan Liposome Company, Ltd. American Depository Shares seller in Q2 2019 was Morgan Stanley, an estimated $1.44M sold.
Based on aggregated 13F filings for Q2 2019.